| First Author | Lichtenegger A | Year | 2018 |
| Journal | Neurophotonics | Volume | 5 |
| Issue | 3 | Pages | 035002 |
| PubMed ID | 30137880 | Mgi Jnum | J:284858 |
| Mgi Id | MGI:6391801 | Doi | 10.1117/1.NPh.5.3.035002 |
| Citation | Lichtenegger A, et al. (2018) Assessment of pathological features in Alzheimer's disease brain tissue with a large field-of-view visible-light optical coherence microscope. Neurophotonics 5(3):035002 |
| abstractText | We implemented a wide field-of-view visible-light optical coherence microscope (OCM) for investigating ex-vivo brain tissue of patients diagnosed with Alzheimer's disease (AD) and of a mouse model of AD. A submicrometer axial resolution in tissue was achieved using a broad visible light spectrum. The use of various objective lenses enabled reaching micrometer transversal resolution and the acquisition of images of microscopic brain features, such as cell structures, vessels, and white matter tracts. Amyloid-beta plaques in the range of 10 to 70 mum were visualized. Large field-of-view images of young and old mouse brain sections were imaged using an automated x-y-z stage. The plaque load was characterized, revealing an age-related increase. Human brain tissue affected by cerebral amyloid angiopathy was investigated and hyperscattering structures resembling amyloid beta accumulations in the vessel walls were identified. All results were in good agreement with histology. A comparison of plaque features in both human and mouse brain tissue was performed, revealing an increase in plaque load and a decrease in reflectivity for mouse as compared with human brain tissue. Based on the promising outcome of our experiments, visible light OCM might be a powerful tool for investigating microscopic features in ex-vivo brain tissue. |
